In both in vitro and in vivo studies, in hepatocellular carcinoma (HCC), the cancer stem cell-like CD133+/CD44+ cells with high OPN levels were more sensitive to DNA methylation inhibitor, 5 Azacytidine (5 Aza). Here, CD44 is linked to hepatocellular carcinoma.